Table 2.
Outcomes of patients with ESBL-KP bacteremia according to antibiotic treatment
| Outcomes | Cefoxitin (n = 63) |
Carbapenem (n = 47) |
Univariate analysis | PS-adjusted analysis (n = 100) |
||
|---|---|---|---|---|---|---|
| HR (95%CI) | p value | aHR (95%CI) | p value | |||
| 30-day clinical success | 36 (57) | 25 (53) | 0.9 (0.5–1.6) | .823 | 1.3 (0.6–2.5) | .497 |
| 30-day all-cause mortality | 18 (29) | 20 (42) | 0.6 (0.3–1.2) | .131 | 0.8 (0.4–1.7) | .549 |
| Relapse | 6 (11) | 4 (11) | 1.1 (0.3–3.9) | .887 | 0.8 (0.1–4.0) | .768 |
| Change of antibiotic | 11 (17) | 0 (0) | N/A | .002 | N/A | N/A |
| 7-day all-cause mortality | 9 (14) | 7 (15) | 0.9 (0.3–2.5) | .889 | 1.5 (0.5–4.8) | .463 |
| Microbiological failure | 10 (16) | 7 (15) | 1.1 (0.4–2.8) | .897 | 1.6 (0.5–5.3) | .414 |
Data are presented as median [IQR] or count (%). p values in bold are statistically significant. aHR = adjusted hazard ratio. N/A = not applicable
*Fisher's exact test used for this variable for which one of the counts is 0